These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 5152441

  • 1. [First experiences with the use of dopamine (hydroxytyramine) in cardiogenic shock].
    Döring D, Fleischmann HJ, Heunisch K, Köhler H, Trenckmann H.
    Z Gesamte Inn Med; 1971 Dec 15; 26(24):759-63. PubMed ID: 5152441
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The use of dopamin in shock and heart failure (author's transl)].
    Aroński A, Kübler A, Sliwinski M, Paszkowska A.
    Anaesthesist; 1978 Apr 15; 27(4):183-6. PubMed ID: 655365
    [Abstract] [Full Text] [Related]

  • 6. [Hemodynamic study of dopamine used in chronic heart failures and in cardiogenic shock as a complication of acute myocardial infarct].
    Flammang D, Sebastien P, Bouvrain Y.
    Ann Anesthesiol Fr; 1975 Dec 15; 16(9):669-72. PubMed ID: 5028
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of dopamine in patients with cardiogenic shock.
    Holzer J, Karliner JS, O'Rourke RA, Pitt W, Ross J.
    Am J Cardiol; 1973 Jul 15; 32(1):79-84. PubMed ID: 4713114
    [No Abstract] [Full Text] [Related]

  • 8. [Cardiovascular effects of hydroxytyramine (dopamine) and its importance for the therapy of cardiogenic shock in heart infarct. 2. Experimental studies on hypodynamic hearts of dogs].
    Urbaszek W, Günther K, Trenckmann H, Döring D.
    Z Gesamte Inn Med; 1970 Apr 01; 25(7):290-3. PubMed ID: 4398843
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Use of dopamine in the treatment of cardiogenic shock. Preliminary results].
    Chiche P, Baligadoo S.
    Ann Anesthesiol Fr; 1975 Dec 01; 16(9):705-10. PubMed ID: 5034
    [Abstract] [Full Text] [Related]

  • 11. The effects of dopamine on cardiogenic and endotoxin experimental shock.
    Marchetti G, Longo T, Merlo L, Noseda V.
    Eur Surg Res; 1973 Dec 01; 5(3):175-85. PubMed ID: 4584042
    [Abstract] [Full Text] [Related]

  • 12. Pathogenesis of cardiogenic shock. I.
    Kones RJ.
    N Y State J Med; 1973 Jun 15; 73(12):1662-70. PubMed ID: 4575582
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Medical tretment and mortality in cardiogenic shock. Metaraminol compared with combined phentolamine and norepinephrine. Glucagon therapy.
    Takkunen J, Oilinki O, Huhti E, Vuopala U, Koivisto O.
    Acta Med Scand; 1972 Sep 15; 192(3):165-70. PubMed ID: 5055261
    [No Abstract] [Full Text] [Related]

  • 16. [Central venous pressure and clinical findings in recent myocardial infarction].
    Buchwalsky R, Zeh E.
    Z Kreislaufforsch; 1972 Feb 15; 61(2):124-34. PubMed ID: 5026176
    [No Abstract] [Full Text] [Related]

  • 17. [Our experience with the treatment of cardiogenic shock in recent myocardial infarction with dopamine and sodium nitroprusside].
    Korewicki J, Ostrzycki A, Opolski G.
    Kardiol Pol; 1984 Feb 15; 27(5):345-51. PubMed ID: 6387246
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Left ventricular systolic intervals as indices of the pharmacological effect of intravenous administration of digoxin and their correlation with blood levels of the drug].
    De Bernardi A, Gastaldi L, Cottino AM, Rusconi O, Zardini P.
    Boll Soc Ital Cardiol; 1975 Feb 15; 20(11):1505-11. PubMed ID: 1234449
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.